Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

"Real-time imaging of glutamate neurotransmission in Huntington disease using iGluSnFR, a fluorescent marker"

EF 2016-17

Résumé
Neurotransmitters are chemical messengers in the brain transmitted between neurons to influence their activity. Glutamate is a neurotransmitter that plays a primary role in activating neurons in the brain. Disruption of glutamate function is thought to cause many neurological disorders, including Huntington Disease (HD). HD is a progressive neurodegenerative disorder that affects the control of movement, cognitive processes and leads to dementia. It is caused by an inherited genetic mutation and there is currently no cure for this disease. Much of the research on HD has focused on glutamate transmission. One hypothesis for HD pathology is that the release of glutamate from neurons is altered, contributing to some of the disease symptoms. However, there is much about glutamate activity in HD that is still not well understood. In my research, I will be using a powerful new genetic tool, the iGluSnFR, to measure glutamate release in live brain tissue. This tool emits a bright green fluorescent signal in response to glutamate. Using genetic mouse models of HD, I will focus on two areas of the brain that are affected in HD, the striatum and the cortex. In addition, I can investigate the effects of drugs that target different neurotransmitter pathways to determine their effects on glutamate signalling. Studying glutamate transmission can allow us to understand how HD affects the brain, and aid in the development of treatments to return glutamate signalling to normal levels. The iGluSnFR can allow us to accurately measure glutamate activity, and experiments made possible by this technique will be beneficial to understanding the causes and possible treatments for HD and other neurological disorders.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367191
Name
Koch Ellen T
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
"Real-time imaging of glutamate neurotransmission in Huntington disease using iGluSnFR, a fluorescent marker"
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Brain Slice Imaging; Biology; Glutamate; Huntington'S Disease; Neurodegenerative Disorders; Neurology; Neuroscience; Neurotransmission; Striatum
Abstract
Neurotransmitters are chemical messengers in the brain transmitted between neurons to influence their activity. Glutamate is a neurotransmitter that plays a primary role in activating neurons in the brain. Disruption of glutamate function is thought to cause many neurological disorders, including Huntington Disease (HD). HD is a progressive neurodegenerative disorder that affects the control of movement, cognitive processes and leads to dementia. It is caused by an inherited genetic mutation and there is currently no cure for this disease. Much of the research on HD has focused on glutamate transmission. One hypothesis for HD pathology is that the release of glutamate from neurons is altered, contributing to some of the disease symptoms. However, there is much about glutamate activity in HD that is still not well understood. In my research, I will be using a powerful new genetic tool, the iGluSnFR, to measure glutamate release in live brain tissue. This tool emits a bright green fluorescent signal in response to glutamate. Using genetic mouse models of HD, I will focus on two areas of the brain that are affected in HD, the striatum and the cortex. In addition, I can investigate the effects of drugs that target different neurotransmitter pathways to determine their effects on glutamate signalling. Studying glutamate transmission can allow us to understand how HD affects the brain, and aid in the development of treatments to return glutamate signalling to normal levels. The iGluSnFR can allow us to accurately measure glutamate activity, and experiments made possible by this technique will be beneficial to understanding the causes and possible treatments for HD and other neurological disorders.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Koch, Ellen T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~